Bridging the Communication Gap

Biotechs and hospitals speak two different languages. Your shared commitment speaks volumes.

Biotech and life science teams have more than a little in common with hospital staff: determination, quick thinking, and a boundless supply of grit. But the pursuit of better patient care happens on opposite sides of a wall, which can make it inherently difficult to understand each others' processes and communicate effectively.

How do you strengthen these partnerships, or forge new ones, if you can’t convey what you have to offer or ask for what you need? With help from experts who understand both languages and perspectives — and can see what’s happening on both sides of the cell collections wall. Terumo Blood and Cell Technologies lives in both worlds, and the Spectra Optia^® Apheresis System is an industry standard for cell collection procedures. Our experts can help you overcome communication barriers with hospital staff and open the gate to better partnerships.

Explore the resources below to get started.

Webinar

Set precise targets for optimal results.

Timing apheresis procedures is a challenge with patients in fragile health, with multiple factors influencing risk, process duration, cell collection quality, and achievement of target yield. A panel of physician and industry experts from Dendreon, BioInsights Publishing, Crispr Therapeutics, Georgia Institute of Technology, and Emory University recently gathered to discuss these challenges in a question-and-answer session. Hear from them how staff training, quality requirements, and data analytics can streamline cell collections for everyone involved, produce higher-quality starting materials, and improve patient outcomes.

View their expert insights on demand.

Watch Now

Presentation

Leverage the power of data, for one and all.

Every research and cell therapy process and endpoint come with specific requirements, but no two patients are exactly alike. For too long, this perceived conflict has prevented biotech and life science organizations from sourcing cell products that truly meet their needs. That’s all changing thanks to the power of data analytics unlocking key insights from apheresis procedure data. Our Spectra Optia Prediction Algorithm service, which sets cell collection targets against benchmarks based on an individual patient’s precount, is just one example of how process standardization can boost overall quality and consistency as it helps improve patient experience.

Find out the difference analytics can make.

Watch Now

Guide

Explore apheresis from A to Z.

Apheresis is key to the promise of cell-based therapies, and technological advancements are stretching cell collection capabilities to new heights. Apheresis has become an intelligent, data-driven, highly customizable process that can adapt to meet your specific needs — if you know how to optimize parameters and unlock the opportunities in data analytics. Elizabeth Valdez of Novartis explores various aspects of cell collections in great depth in content co-written with our own experts Erin Goodhue and Dalip Sethi.

See Chapter 5, "Cell Collection and Starting Materials Consideration," in this industry guide.

Learn More

Video

Collaborate for better outcomes.

When sick patients entrust their hopes of recovery to emerging cell therapies, cell collections and research teams have vital roles to play. In this video, Simone Steiner, Head of Technical Development and Manufacturing at Tigen Pharma SA, reveals how starting materials impact the efficacy of cell therapy products and ultimately patient outcomes.

Uncover the link between apheresis and clinical results.

Learn More

Next up: Demystifying cell collections and improving starting material consistency.

Learn More

Complete the form below to connect with our Veda Solutions team for more information.

Fields marked * are required

First Name:*

Last Name:*

Email:*

Country:*

Institution Type:*

Role:*

Title:*

Company:*

Yes, I would like to receive future communications about Terumo Blood and Cell Technologies.

I confirm that I have read and agree to the Terumo Blood and Cell Technologies Privacy Policy.*

Submit

All products and solutions may not be available in all regions. Contact your Terumo Blood and Cell Technologies representative.

{{$index+1}}. {{s.label}}